Wir überwinden Grenzen

Prof. Dr. Leena Bruckner-Tuderman will explain what rare diseases are and how new therapies are developed in the lecture series "One hour of cutting-edge research" on March 10, using the example of rare skin diseases

Around four million people in Germany are affected by a rare disease. Much has been done in recent years in the research and treatment of these more than 6,000 diseases. What rare diseases are, why they are the focus of European health policy and how molecular research can help many of the patients will be discussed by Prof. Dr. Dr. h.c. Leena Bruckner-Tuderman, Medical Director of the Department of Dermatology and Venereology and spokesperson for the Freiburg Center for Rare Diseases at the Medical Center - University of Freiburg, will talk about this on

Wednesday, March 10, 2021
at 6:30 pm

in an online lecture entitled "Rare diseases of the skin - challenges and therapeutic perspectives". The livestream of the lecture will be broadcast at www.uniklinik-freiburg.de/1hspitzenforschung. There will be an opportunity for questions after the 40-minute lecture.

Personal details:

Bruckner-Tuderman studied medicine at the University of Oulu, Finland. After a research stay in the USA, she first worked at the Biozentrum of the University of Basel and later at the University Hospital Zurich, where she also habilitated. After a stint in Münster, Bruckner-Tuderman has been Head of the Department of Dermatology and Venereology at the Medical Center - University of Freiburg since 2003. From 2012 to 2019, she was Vice President of the German Research Foundation, the most important source of research funding in Germany with a budget of over three billion euros. Bruckner-Tuderman has been a member of the German National Academy of Sciences - Leopoldina since 2007. In 2009, she was awarded the Eva Luise Köhler Research Prize for Rare Diseases.

The lecture series

The lecture is part of the series "One Hour of Cutting-Edge Research" organized by the Medical Center - University of Freiburg and the Faculty of Medicine - University of Freiburg, in which Freiburg members of the German National Academy of Sciences - Leopoldina give a broad audience insights into their research. The series is supported by the Leopoldina.

Further dates:

• May 5, 2021, 6.30 p.m.
  Prof. Dr. Stephan Ehl, Medical Director of the Centre for Chronic Immunodeficiency
  Benefit and harm from the immune system - a delicate balance
• June 9, 2021, 6.30 pm
  Prof. Dr. Dr. med. Katharina Domschke, Medical Director of the Department of Psychiatry and Psychotherapy
  Epigenetics - the interface between risk and resilience in mental illnesses
• 7 July 2021, 6.30 p.m.
  Prof. Dr. Charlotte Niemeyer, Medical Director of the Department of Pediatric Hematology and Oncology
  Hereditary predisposition as a risk factor for leukemia

Contact:
Johannes Faber
Press and Public Relations Officer
Uniklinik Freiburg
Phone: 0761 270-84610
johannes.faber@uniklinik-freiburg.de